1. Home
  2. XPL vs VNRX Comparison

XPL vs VNRX Comparison

Compare XPL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.72

Market Cap

62.5M

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.28

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
VNRX
Founded
1984
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XPL
VNRX
Price
$0.72
$0.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.20
$2.50
AVG Volume (30 Days)
246.9K
2.2M
Earning Date
10-31-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$0.54
$0.22
52 Week High
$0.90
$0.94

Technical Indicators

Market Signals
Indicator
XPL
VNRX
Relative Strength Index (RSI) 60.82 48.56
Support Level $0.64 $0.22
Resistance Level $0.70 $0.26
Average True Range (ATR) 0.04 0.02
MACD 0.01 0.01
Stochastic Oscillator 89.89 71.61

Price Performance

Historical Comparison
XPL
VNRX

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: